Arachidonate 12-lipoxygenase is an enzyme that oxygenates the 12 position of arachidonic acid to produce its 12hydroperoxy derivative. We were interested in the tissue distribution and subcellular localization of the platelet-type 12lipoxygenase, which is distinguished from the leukocyte type by several criteria. Antiserum was raised in rabbits against purified recombinant arachidonate 12-lipoxygenase of human platelets. When mouse bone " o w cells and lung were immunostained and observed by light and electron microscopy, the positively stained cells were platelets, megakaryocytes, and eosinophils. 12-Lipoxygenase was localized in the cytoplasm of platelets but was hardly detectable in the plasma
Introduction
Arachidonate 12-lipoxygenase introduces an oxygen molecule specifically into c-12 of amchidonic acid. The product is 12-hydroperoxy arachidonic acid , which is readily reduced to 12-hydroxy acid . A number of papers have reported biological activities of either 12-HPETE or 12-HETE in certain animal tissues (27) . Until recently, however, no metabolites with specific biological activities, such as prostaglandins, thromboxanes, and leukotrienes, had been found in the pathway initiated by 12-lipoxygenase, and the general biological significance of the enzyme remained unclarified (2, 27) . Recently, 12-lipoxygenase has been found to be involved in the biosyntheses of two groups of bioactive arachidonate metabolites. Transcellular synthesis of lipoxins via leukotriene A4 requires the participation of platelet 12-lipoxygenase (19) . Moreover, a 12-lipoxygenase product (12-HPETE) was shown to be enzymatically transformed to hepoxilins (17) . Therefore, the enzyme is now a subject of active investigation from the physiological point of view.
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Correspondence to: Prof. Shozo Ymamoto, Dept. of Biochemistry, Tokushima U. School of Medicine, Kuramoto-cho. Tokushima 770. Japan. membrane and intracellular organelles. The enzyme was found in the cytoplasm of immature megakaryocytes with kidney-shaped nuclei and a few profdes of demarcation membranes, as well as in the mature form with well-developed demarcation membranes. These results indicated the expression of 12-lipoxygenase at an early stage in the course of megakaryucytopoiesis. platelets and was later detected in many other mammalian tissues (27) . Enzymological, immunological, and molecular biological studies have demonstrated two distinct isoforms of 12-lipoxygenase (27) . The leukocyte-type 12-lipoxygenase has a broad substrate specificity, reacting with cl8 and C22 unsaturated fatty acids as well as with Czo fatty acids such as arachidonic acid. In contrast, the platelet-type enzyme is much less active with cl8 fatty acids compared with arachidonic acid. The latter isozyme was found not only in platelets of various animal species but also in human keratinocytes (22) .
Previously we purified 12-lipoxygenase from porcine leukocytes (28) , and an antiserum was raised for the purified enzyme (15) . With this antibody, immunohistochemical studies were performed on the leukocyte-type enzyme (15, 26) . However, purification of platelet 12-lipoxygenase was difficult at that time, and no antibody useful for immunohistochemical studies has thus far been available. Recently, the cDNA encoding human platelet 12lipoxygenase was isolated and a recombinant enzyme was expressed (5, 10, 29) . We could now purify the recombinant enzyme and prepared antiserum with a high affinity for platelet 12-lipoxygenase. With this antiserum we attempted an approach to a still unsolved problem of the subcellular localization of the enzyme in platelets, since the enzyme activity was previously recovered in the cytosol, the membrane fraction, or both (3, 6, 8, 16, 23) . We also tried to follow the expression of the enzyme in megakaryocytes during their maturation.
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Materials and Methods
Materials. Freund's complete and incomplete adjuvants and sodium borohydride were purchased from Wako Pure Chemical Industries (Osaka, Japan), OCT compound (embedding medium for frozen sections) for Miles Laboratories (Naperville, IL), Os04 and paraformaldehyde from Merck (Darmstadt, Germany), Vectastain ABC kit and biotinylated goat anti-rabbit IgG antibody from Vector Laboratories (Burlingame, CA), bovine serum albumin fraction V from Sigma (St Louis, MO), 3,3'-diaminobenzidine (DAB) from Dojin (Kumamoto, Japan), high molecular weight standard mixture for SDS-PAGE from Bio-Rad Laboratories (Richmond, CA), Immobilon-P membrane from Millipore (Bedford, MA), pQE-32 vector and Ni2+-NTA resin from Quiagen (Hilden, Germany), enhanced chemiluminescence Western blotting detection reagents from Amersham (Poole, UK), arachidonic acid from Nu-Chek Prep (Elysian, MN), Epon-812, DDSA, MNA, and DMP-30 from TAAB (Reading, UK). 12-Hydroxy-5,8.14-cis-10trans-eicosatetraenoic acid (12-HETE), 15-hydroxy-5,8,11-czs-l3-truns-eicosatetraenoic acid (15-HETE), and 13-hydroxy-9-cis-ll-trans-octadecadienoic acid (13-HODE) were enzymatically synthesized as described previously (23) .
Preparation of Polydonal Antibody. cDNA of human platelet 12lipoxygenase (29) was cloned into the pQE-32 vector with a hexahistidine sequence attached to the amino terminus of the enzyme. E. coli cells expressing hexahistidine-tagged 12-lipoxygenase were suspended in 20 mM potassium phosphate buffer (pH 7.4) containing 150 mM NaCl and 1% Triton X-100, and then the suspension was sonicated. All subsequent steps were carried out at 4°C. The sonicate was centrifuged at 10,000 x g for 10 min and the supernatant was further centrifuged at 105,000 x g for 40 min. The high-speed supernatant was fractionated by ammonium sulfate, and the fraction obtained at 20-50% saturation was mixed with Ni2'-NTA resin in 20 mM potassium phosphate buffer (pH 7.4) containing 150 mM NaCl and 1% Triton X-100. After 1 hr the resin was packed into a column and washed with 100 bed volumes of 50 mM potassium phosphate buffer (pH 7.4) containing 300 mM NaCl and 80 mM imidazole. The hexahistidine-tagged 12-lipoxygenase was eluted with 3 bed volumes of 50 mM potassium phosphate buffer (pH 7.4) containing 250 mM imidazole. The enzyme thus purified (540 pg protein/0.75 ml) was emulsified with an equal volume of Freund's adjuvant and the emulsion was injected SC at multiple sites along the back of a Japanese white rabbit. The first injection with Freund's complete adjuvant was followed by injections with Freund's incomplete adjuvant after 4 and 8 weeks. The antiserum was titrated by peroxidase-linked immunoassay in 96-well immunoplates. The animal was bled 12 days after the final injection, and the serum fraction was prepared.
Enzyme Preparation and Assay. Murine whole blood (10 ml) was obtained from 12 animals, and mixed with one ninth the volume of 3.8% trisodium citrate (pH 7.4). The mixture was centrifuged at 200 x g for 10 min and the upper layer was further centrifuged at 1500 x g for 20 min. The platelet pellet was washed once in PBS, pH 7.4, containing 1 mM EDTA and then re-suspended in 300 p1 of PBS. Human Platelets were prepared as described before (6) . The mouse and human platelets were sonicated at 25 kHz for 1 min and the lysates were centrifuged at 10,000 x g for 60 min. The supernatant was used for enzyme assay and immunoblotting. The 12-lipoxygenase preparations were incubated with 25 pM arachidonic acid in 200 pI of 100 mM Tris-HCI buffer (pH 7.4). After the enzyme reaction at 30'C for 5 min, sodium borohydride (0.2 mg) was added for reduction of hydroperoxy products to hydroxides, and 13-HODE (1 nmol) was added as an internal standard. The products were acidified, extracted with diethyl ether, and analyzed by reverse-phase high-performance liquid chromatography with a Waters 6000A pump and a TSK ODS-120T column ( 5 pm particle; 4.6 x 250 mm) (Tosoh; Tokyo, Japan). The mobile phase was a mixture of methano1:water:acetic acid (77:23:0.01) at a flow rate of 1 mllmin. Absorbance at 235 nm due to a conjugated diene was monitored by a Waters dual wavelength detector model 490 and a Shimadzu C-R4A Chromatopac.
Immunoblotting. Purified hexahistidine-tagged 12-lipoxygenax (0.013 pg of protein) and the 10.000 x g supernatants of human platelets (45 pg of protein) and mouse platelets (45 pg of protein) were subjected to 8.5% PAGE in the presence of 0.1% SDS (11) . Proteins were then transferred electrophoretically from the gel to an Immobilon-P membrane in a Marysol gel electrophoresis apparatus (model KS-8440GMT) by the method of Towbin et al. (24) . All subsequent steps were carried out at mom temperature (RT). After blocking with 5 % bovine serum albumin dissolved in PBS, the membrane was probed with the antiserum for the hexahistidinetagged 12-lipoxygenase (1:5000 dilution) for 60 min. The immunocomplexes were incubated with biotinylated goat anti-rabbit IgG antibody (4.5 pglml) for 30 min and then with avidin-biotin-peroxidase complex for 30 min. The immunoreaction was detected with the aid of the enhanced chemiluminescence method. Protein concentration was determined by the method of Lowry et al. (13) , with bovine serum albumin as standard.
Immunostaining for Light and Electron Microscopy. Mice were sacrificed by cervical dislocation. The lungs were removed and cut into pieces (8 mm x 8 mm x 5 mm). Femoral marrow was flushed from the bones with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). The bone marrow cells were repeatedly dispersed into a single-cell suspension through a 22gauge needle. Bone marrow cells and lung were fixed with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) for 12 hr at 4°C and then rinsed sequentially with PBS containing 10, 15, and 20% sucrose for 4 hr. The tissues and cells thus fixed were placed in OCT compound and frozen at -8O'C. Frozen sections (6 pm thick) were prepared with a cryostat and mounted on ovalbumin-coated glass slides. All subsequent steps were carried out at RT unless otherwise noted. The sections on glass slides were air-dried and rinsed three times with PBS, followed by treatment with 1% H202 in PBS for 30 min for inhibition of endogenous peroxidase and pseudoperoxidase activities according to a previous method (9). The glass slides with the specimens were incubated sequentially with anti-12-lipoxygenase antiserum (1:2000 dilution) at 4°C overnight in a moist chamber, with goat biotinylated anti-rabbit IgG for 1 hr, and with avidin-biotin-peroxidase complex for 30 min. The immunoreactant was visualized by staining with 0.02% DAB and 0.03% H202, and observed by light microscopy. Control sections were treated with pre-immune rabbit serum instead of the first antibody. For electron microscopic immunocytochemistry, the peroxidase reaction was carried out as described above. Then the sections were treated with 2% Os04 dissolved in 0.1 M sodium phosphate buffer at pH 7.4 (osmium black formation), dehydrated in a graded series of ethanols, and embedded in Epon epoxy resin. Ultra-thin sections were cut with a Reichert Ultracut and were observed with a Hitachi HSOO electron microscope.
Results
12-Lzpoxygenase Activity in Platelets
The 10,000 x g supernatant of homogenates of mouse and human platelets was incubated with arachidonic acid for assay of 12lipoxygenase activity. The products were reduced with borohydride and analyzed by reverse-phase high-performance liquid chromatography. Absorption at 235 nm was monitored for detection of a conjugated diene of hydroxy derivatives of arachidonic acid. As compared with authentic 12-HETE with a retention time of 24 min ( Figure 1A) , human ( Figure 1B ) and mouse ( Figure 1C) platelets showed comparable 12-lipoxygenase activity.
Specz3city of Antiserum
The rabbit antiserum against human platelet 12-lipoxygenase immunoblotting of the human and mouse platelet lysates as well as the purified recombinant human platelet 12-lipoxygenase (Figure 2) . The result showed that the antibody reacted with the mouse enzyme, although the antibody was raised against the human enzyme. The recombinant 12-lipoxygenase ran slightly more slowly than native platelet 12-lipoxygenase. According to the manufacturer's instructions, "Some proteins with hexahistidine tags attached run more slowly on SDS gels than equivalent untagged proteins, and may appear to be several kDa larger than expected." The reason for such a slow migration is unknown. The antibody did not give a positive band with an equivalent amount of porcine leukocyte 12-lipoxygenase.
Light Microscopic Immunocytochemistry
When mouse bone marrow cells were immunostained with the anti-12-lipoxygenase antiserum, positive cells were scattered as observed by light microscopy (Figure 3a ). Huge cells presumed to be megakaryocytes were positively stained, but some smaller cells were also stained. No positive cells were observed with non-immune rabbit serum in place of the anti-12-lipoxygenase antiserum (Figure 3b ). For the immunoabsorbance test, the anti-12-lipoxygenase antiserum was incubated with the purified hexahistidine-tagged 12- lipoxygenase at 4°C overnight. The antiserum thus treated failed to stain any bone marrow cells. Positive cells were also found in blood capillaries of mouse lung (Figure 3c ). In control sections there were no positive cells (Figure 3d ).
Electron Microscopic Immunocytochemistry
The immunostained cells described above were further observed by electron microscopy. Platelets among bone marrow cells were positively stained (Figure 4a ). The positively stained cells in the lung capillaries were also platelets ( Figure 4c ). Platelets contained in these tissues were fixed with paraformaldehyde and embedded in Epon epoxy resin so that their structure, such as membrane and granules, would be well preserved. 12-Lipoxygenase was detected in the cytoplasm (Figure 4a ) in contrast to a control using the nonimmune rabbit serum (Figure 4b ). The plasma membranes and subcellular organelles were devoid of the dark deposits of immunoperoxidase reaction products. Megakaryocytes were also immunostained among mouse bone marrow cells (Figures 5a, 5c , and 5e). In the megakaryocytes shown in Figures Sa and 5c , welldeveloped demarcation membranes and irregularly lobulated nuclei were observed, characteristic of mature cells. 12-Lipoxygenase was found in the cytoplasm but not in the nucleus, mitochondria, dense bodies, granules, Golgi cistemae, rough endoplasmic reticula, and plasma membranes (Figures 5c and 5e) . A control experiment using the non-immune rabbit serum gave no positive immunoperoxidase reaction products (Figures 5b and 5d ).
As shown in Figure 5f , there was an immunostained large cell that had a kidney-shaped nucleus and poorly developed demarcation membranes. These features are typical of the early stage of megakaryocytes. As was the case with well-matured megakaryocytes, immunoperoxidase reaction products were detected in the cytoplasm of the early-stage cells.
Eosinophils were also positively stained among bone marrow cells, and immunoperoxidase reaction products were detected in the cytoplasm but not in the plasma membranes (Figure 6a ). The granules showed high density even in the eosinophils treated with non-immune rabbit serum as a control (Figure 6b ). Other types of cells observed were negative: neutrophils (Figure 6a ) and lymphocytes ( Figure 5a ) among bone marrow cells, erythrocytes, alveolar cells, and endothelial cells of capillaries in the lung (Figure 4c ).
Discussion
Previously we examined immunohistochemically the leukocyte-type 12-lipoxygenase in porcine tissues. The enzyme was localized in various types of granulocyte (15) and anterior pituitary cells (26) . 
12-LIPOXYGENASE IN MOUSE BLOOD CELLS
1
However, immunohistochemical studies on the platelet-type isozyme have not been performed until recently. 12-Lipoxygenase activity was earlier demonstrated in a human megakaryoblastic DAM1 cell line (20) . A recent paper by Chen et al. (4) employing immunofluorescence microscopy reported the cytosolic localization of the platelet-type 12-lipoxygenase in the same cell line. Mouse platelets had 12-lipoxygenase activity comparable with that of human platelets (Figure 1) . Western blotting demonstrated that our antiserum against human platelet 12-lipoxygenase crossreacted with the mouse (Figure 2) . Therefore, immunocytochemical studies were performed with mouse tissues.
For a long time the cytosol fraction of platelets of various animal species (human, ox, rat, horse, and sheep) has been used as the source of 12-lipoxygenase (3,6,16,23). Nugteren (16) reported that the 12-lipoxygenase in bovine platelets was a soluble enzyme. However, according to Ho et al. (8) . the enzyme activity was present exclusively in the membrane fraction of human platelets. Lagarde et al. (12) examined the subcellular localization of the enzyme ac- tivity in human platelets. Approximately 65%, 20%. and 8% of the total activity were found in the cytosol, mixed membranes, and granules, respectively. Thus, there was a discrepancy in the subcellular localization of the enzyme among these reports. It is possible that the enzyme is loosely bound to the membranes and that the originally membrane-bound enzyme is dissociated during the procedures of the enzyme preparation, especially by sonic disruption or by freezing and thawing. Another possibility that cannot be ruled out is that the enzyme is originally soluble but is associated with the membrane during the enzyme preparation. Furthermore, there is a report that the soluble 12-lipoxygenase of rat platelets is translocated to the cell membrane when the platelet homogenate is incubated with CaZ' (1).
On immunoelectron microscopic observation, the intracellular organelles or the cell surface should be distinctly rimmed with dark deposits of the peroxidase products if the enzyme is attached to these membranes. 12-Lipoxygenase was exclusively localized in the cytoplasm of murine platelets found in bone marrow at the level of magnification used in our present work (Figure 4a ). The enzyme was also localized in the cytoplasm of peripheral platelets in capillaries of lung (Figure 4c ). Our conclusion may be limited to some degree of species variation, and must await further investigation with other animal species.
In addition to platelets, eosinophils were positively stained with antiserum against the platelet-type 12-lipoxygenase ( Figure 6a ). The result is consistent with a previous finding that murine eosinophils possess a 12-lipoxygenase activity (25) . However, we reported previously that porcine eosinophils were immunostained with antibody for the leukocyte-type 12-lipoxygenase (15) . It is technically difficult to collect a sufficient amount of murine eosinophils and to prepare a cell-free 12-lipoxygenase preparation for tests of sub-strate specificity and immunogenicity. Therefore, it cannot be definitely concluded at present whether murine eosinophil 12lipoxygenase is a platelet-type isozyme or whether it is a leukocytetype isozyme crossreacting with the antibody raised against human platelet-type 12-lipoxygenase.
Human erythroleukemia (HEL) cells, exhibiting several megakaryocytelplatelet-like properties, contain the platelet-type 12lipoxygenase (5.10.14.29) . but the occurrence of 12-lipoxygenase in native megakaryocytes has not been definitively demonstrated. Here we present electron microscopic evidence that 12-lipoxygenase is actively expressed in immature megakaryocytes (Figure 5f ) as well as in mature cells (Figures 5a, 5c , and 5e). The enzyme was localized exclusively in the cytoplasm of megakaryocytes (Figures Sa. 5c, and 5e). It has been reported that lipoxygenase inhibitors blocked the myelopoiesis induced by colony-stimulating factor and phor-bo1 myristate acetate and that erythropoiesis stimulated by erythropoietin (21) . It is also well known that the 15-lipoxygenase abundant in reticulocytes attacks the lipids of the mitochondrial membrane and accelerates the maturation of reticulocytes to erythrocytes (18) . Taken together, our evidence suggests that 12-lipoxygenase plays a certain role in the course of megakaryocytopoiesis, which may be a possible function of the enzyme. 
